X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-06 | MGX | Wein Matthew | See Remarks | S - Sale | $1.75 | -199 | 16,693 | -1% | -$348 | ||||||
2025-06-06 | MGX | Noonberg Sarah B. | Chief Medical Officer | S - Sale | $1.75 | -5,239 | 109,135 | -5% | -$9,168 | ||||||
2025-06-06 | MGX | Wapnick Pamela | CFO | S - Sale | $1.75 | -1,576 | 72,108 | -2% | -$2,758 | ||||||
2025-06-06 | MGX | Thomas Brian C. | CEO | S - Sale | $1.75 | -10,785 | 2,517,491 | 0% | -$18,874 | ||||||
2025-06-06 | MGX | Irish Jian | See Remarks | S - Sale | $1.75 | -6,390 | 315,543 | -2% | -$11,183 | ||||||
2025-03-05 | MGX | Wein Matthew | See Remarks | S - Sale | $1.87 | -930 | 9,467 | -9% | -$1,744 | ||||||
2025-03-05 | MGX | Wapnick Pamela | CFO | S - Sale | $1.87 | -1,808 | 59,684 | -3% | -$3,390 | ||||||
2024-12-05 | MGX | Wapnick Pamela | CFO | S - Sale | $1.86 | -1,559 | 61,492 | -2% | -$2,900 | ||||||
2024-09-05 | MGX | Wapnick Pamela | CFO | S - Sale | $2.88 | -6,265 | 63,051 | -9% | -$18,043 | ||||||
| DM | 2024-02-09 | MGX | Novo Holdings A/s | 10% | P - Purchase | $14.47 | +900,000 | 1,739,175 | +107% | +$13,025,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |